ANI Pharmaceuticals
Stock Forecast, Prediction & Price Target
ANI Pharmaceuticals Financial Estimates
ANI Pharmaceuticals Revenue Estimates
ANI Pharmaceuticals EBITDA Estimates
ANI Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $216.13M N/A | $316.38M 46.38% | $486.81M 53.86% | Avg: $627.25M Low: $581.77M High: $712.36M avg. 28.84% | Avg: $646.98M Low: $612.46M High: $704.94M avg. 3.14% | Avg: $648.58M Low: $613.98M High: $706.68M avg. 0.24% | Avg: $682.66M Low: $646.24M High: $743.82M avg. 5.25% |
Net Income
% change YoY
| $-42.60M N/A | $-47.89M -12.42% | $18.77M 139.20% | Avg: $47.70M Low: $34.93M High: $65.31M avg. 154.03% | Avg: $80.6M Low: $68.59M High: $92.42M avg. 68.95% | Avg: $118.32M Low: $110.11M High: $132.10M avg. 46.80% | Avg: $133.30M Low: $124.05M High: $148.82M avg. 12.66% |
EBITDA
% change YoY
| $14.74M N/A | $31.90M 116.47% | $106.59M 234.08% | Avg: $103.50M Low: $96.00M High: $117.55M avg. -2.90% | Avg: $106.76M Low: $101.06M High: $116.32M avg. 3.14% | Avg: $107.02M Low: $101.31M High: $116.61M avg. 0.24% | Avg: $112.65M Low: $106.64M High: $122.74M avg. 5.25% |
EPS
% change YoY
| -$3.38 N/A | -$2.95 12.72% | $0.95 132.20% | Avg: $2.62 Low: $1.92 High: $3.59 avg. 175.78% | Avg: $4.43 Low: $3.77 High: $5.08 avg. 68.89% | Avg: $6.5 Low: $6.05 High: $7.26 avg. 46.96% | Avg: $7.33 Low: $6.82 High: $8.18 avg. 12.66% |
Operating Expenses
% change YoY
| $143.69M N/A | $203.33M 41.50% | $258.33M 27.04% | Avg: $212.80M Low: $197.37M High: $241.67M avg. -17.62% | Avg: $219.49M Low: $207.78M High: $239.16M avg. 3.14% | Avg: $220.04M Low: $208.30M High: $239.75M avg. 0.24% | Avg: $231.60M Low: $219.24M High: $252.35M avg. 5.25% |
FAQ
What is ANI Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 70.61% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is 34.93M, average is 47.70M and high is 65.31M.
What is ANI Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.37% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $581.77M, average is $627.25M and high is $712.36M.
What is ANI Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 76.07% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is $1.92, average is $2.62 and high is $3.59.
What is the best performing analyst?
In the last twelve months analysts have been covering ANI Pharmaceuticals stock. The most successful analyst is Oren Livnat.